Investigation of Linac-Based Image-Guided Hypofractionated Prostate Radiotherapy

Medical Dosimetry

Volumn 32, Issue 2, 2007, Pages 71-79

  Pawlicki, Todd ^a   Kim, Gwe Ya ^a   Hsu, Annie ^a   Cotrutz, Cristian ^a   Boyer, Arthur L ^a   Xing, Lei ^a   King, Christopher R ^a   Luxton, Gary ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Image guidance; IMRT; Linac based; Prostate hypofractionation

Indexed keywords

ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; CYSTITIS; DEVICE; DIARRHEA; HISTOGRAM; HUMAN; IMAGING SYSTEM; INTENSITY MODULATED RADIATION THERAPY; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; RADIATION DOSE;

DOSE FRACTIONATION; HUMANS; MALE; PARTICLE ACCELERATORS; PROSTATIC NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34247493689     PISSN: 09583947     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meddos.2007.01.004     Document Type: Article

References (26)

1. King C.R., Cotrutz C., et al. Hypo-fractionated radiotherapy for localized prostate cancer: Therapeutic rationale and feasibility of the CyberKnife. In: Mould R.F. (Ed). Robot Radiosurgery Vol. 1 (2005), The CyberKnife Society Press, Sunnyvale 315-323
2. King C.R., Lehmann J., Adler J.R., et al. CyberKnife radiotherapy for localized prostate cancer: Rationale and technical feasibility. Technol. Cancer Res. Treat. 2 (2003) 25-30
3. King C.R., Presti J., Harcharan G., et al., Stanford University IRB Panel. Hypofractionated Radiotherapy for Localized Prostate Cancer (2004) Vol. Protocol ID 79432
4. King C.R., and Fowler J.F. A simple analytic derivation suggests that prostate cancer alpha/beta ratio is low. [see comment]. Int. J. Radiat. Oncol. Biol. Phys. 51 (2001) 213-214
5. Fowler J., Chappell R., and Ritter M. Is alpha/beta for prostate tumors really low?. [see comment]. Int. J. Radiat. Oncol. Biol. Phys. 50 (2001) 1021-1031
6. Brenner D.J. Toward optimal external-beam fractionation for prostate cancer. [see comment]. Int. J. Radiat. Oncol. Biol. Phys. 48 (2000) 315-316
7. Brenner D.J., and Hall E.J. Fractionation and protraction for radiotherapy of prostate carcinoma. [see comment]. Int. J. Radiat. Oncol. Biol. Phys. 43 (1999) 1095-1101
8. Brenner D.J., Martinez A.A., Edmundson G.K., et al. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue. [see comment]. Int. J. Radiat. Oncol. Biol. Phys. 52 (2002) 6-13
9. Lloyd-Davis R.W., Collins C.D., and Swan A.V. Carcinoma of prostate treated by a radical external beam radiotherapy using hypofractionation: 22 years experience (1962-1984). Urology 36 (1990) 107-111
10. Kupelian P.A., Reddy C.A., Klein E.A., et al. Short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: preliminary results on late toxicity and quality of life. [see comment]. Int. J. Radiat. Oncol. Biol. Phys. 51 (2001) 988-993
11. Koukourakis M., Touloupidis S., Manavis J., et al. Conformal hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC) for high risk prostatic carcinoma: Rationale, technique and early experience. Anticancer Res. 24 (2004) 3239-3243
12. Martinez A.A., Pataki I., Edmundson G., et al. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: A feasibility report. Int. J. Radiat. Oncol. Biol. Phys. 49 (2001) 61-69
13. Hall E.J. Radiobiology for the Radiologist. 4th ed. (1994), J.B. Lippincott Company, Philadelphia
14. Fowler J.F., Ritter M.A., Chappell R.J., et al. What hypofractionated protocols should be tested for prostate cancer?. Int. J. Radiat. Oncol. Biol. Phys. 56 (2003) 1093-1104
15. Byrne T.E. A review of prostate motion with considerations for the treatment of prostate cancer. Med. Dosim. 30 (2005) 155-161
16. Malone S., Crook J.M., Kendal W.S., et al. Respiratory-induced prostate motion: Quantification and characterization. Int. J. Radiat. Oncol. Biol. Phys. 48 (2000) 105-109
17. Kitamura K., Shirato H., Seppenwoolde Y., et al. Three-dimensional intrafractional movement of prostate measured during real-time tumor-tracking radiotherapy in supine and prone treatment positions. Int. J. Radiat. Oncol. Biol. Phys. 53 (2002) 1117-1123
18. Bayley A.J., Catton C.N., Haycocks T., et al. A randomized trial of supine vs. prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancer. Radiother. Oncol. 70 (2004) 37-44
19. Kitakura K., Shirato H., Shinohara K., et al. Reduction in acute morbidity using hypofractionated intensity-modulated radiation therapy assisted with a fluoroscopic real-time tumor-tracking system for prostate cancer: Preliminary results of a phase I/II study. Cancer J. 9 (2003) 268-276
20. Cheung P., Sixel K., Morton G., et al. Individualized planning target volumes for intrafraction motion during hypofractionated intensity-modulated radiotherapy boost for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 62 (2005) 418-425
21. Amer A.M., Mott J., MacKay R.I., et al. Prediction of the benefits from dose-escalated hypofractionated intensity-modulated radiotherapy for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 56 (2003) 199-207
22. Song W., Schaly B., Gauman G., et al. Image-guided adaptive radiation therapy (IGART): Radiobiological and dose escalation considerations for localized carcinoma of the prostate. Med. Phys. 32 (2005) 2193-2203
23. Craig T., Moiseenko V., Battista J., et al. The impact of geometric uncertainty on hypofractionated external beam radiation therapy of prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 57 (2003) 833-842
24. Huang E., Dong L., Chandra A., et al. Intrafraction prostate motion during IMRT for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 53 (2002) 261-268
25. Nederveen A.J., van der Heide U.A., Dehnad H., et al. Measurements and clinical consequences of prostate motion during a radiotherapy fraction. Int. J. Radiat. Oncol. Biol. Phys. 53 (2002) 206-214
26. Britton K.R., Takai Y., Mitsuya M., et al. Evaluation of inter- and intrafraction organ motion during intensity modulated radiation therapy (IMRT) for localized prostate cancer measured by a newly developed on-board image-guided system. Radiat. Med. 23 (2005) 14-24